St Jean, P. L., Xue, Z., Carter, N., Koh, G. C. K. W., Duparc, S., Taylor, M., . . . Rubio, J. P. (2016). Tafenoquine treatment of Plasmodium vivax malaria: Suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial. Malar J.
Citação norma ChicagoSt Jean, Pamela L., et al. "Tafenoquine Treatment of Plasmodium Vivax Malaria: Suggestive Evidence That CYP2D6 Reduced Metabolism Is Not Associated With Relapse in the Phase 2b DETECTIVE Trial." Malar J 2016.
ציטוט MLASt Jean, Pamela L., et al. "Tafenoquine Treatment of Plasmodium Vivax Malaria: Suggestive Evidence That CYP2D6 Reduced Metabolism Is Not Associated With Relapse in the Phase 2b DETECTIVE Trial." Malar J 2016.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.